Blood Adv

ISSN	2473-9529
ISSN-L	-
IUID	2fae45c4042e474a95dae9815a079228
Modified	2023-11-20T11:21:38.869Z
Created	2023-11-20T11:21:38.869Z

Year 2025

PubMed DOI Crossref

Multipopulation GWAS for venous thromboembolism identifies novel loci followed by experimental validation in zebrafish.

Wolford BN, Zhao QY, Wu KH, ..., Shavit JA, Surakka I

Blood Adv 9 (19) 4850-4859 [2025-10-14; online 2025-06-24]

PubMed DOI Crossref

Dual targeting of G9a and DNMTs induces antitumor effects in multiple myeloma.

Nylund P, Garrido-Zabala B, Tziola SI, ..., Kalushkova A, Wiklund HJ

Blood Adv 9 (19) 4825-4841 [2025-10-14; online 2025-07-17]

Year 2024

PubMed DOI Crossref

Risk factors for clonal hematopoiesis of indeterminate potential in people with HIV: a report from the REPRIEVE trial.

Bhattacharya R, Uddin MM, Patel AP, ..., Grinspoon SK, Natarajan P

Blood Adv 8 (4) 959-967 [2024-02-27; online 2024-01-10]

Abhishek Niroula DDLS Fellow

Year 2023

PubMed DOI Crossref

Allelic variation of KIR and HLA tunes the cytolytic payload and determines functional hierarchy of NK cell repertoires.

Philippon C, Tao S, Clement D, ..., Norman PJ, Malmberg KJ

Blood Adv 7 (16) 4492-4504 [2023-08-22; online 2023-06-16]

PubMed DOI Crossref

BTK and PLCG2 remain unmutated in one-third of patients with CLL relapsing on ibrutinib.

Bonfiglio S, Sutton LA, Ljungström V, ..., Rosenquist R, Ghia P

Blood Adv 7 (12) 2794-2806 [2023-06-27; online 2023-01-26]

Year 2022

PubMed DOI Crossref

Linked-read whole-genome sequencing resolves common and private structural variants in multiple myeloma.

Peña-Pérez L, Frengen N, Hauenstein J, ..., Lindstrand A, Månsson R

Blood Adv 6 (17) 5009-5023 [2022-09-13; online 2022-06-09]

PubMed DOI Crossref

Fibrin protofibril packing and clot stability are enhanced by extended knob-hole interactions and catch-slip bonds.

Asquith NL, Duval C, Zhmurov A, ..., Barsegov V, Ariëns RAS

Blood Adv 6 (13) 4015-4027 [2022-07-12; online 2022-05-14]

PubMed DOI Crossref

Transcriptomic analysis reveals proinflammatory signatures associated with acute myeloid leukemia progression.

Stratmann S, Yones SA, Garbulowski M, ..., Komorowski J, Holmfeldt L

Blood Adv 6 (1) 152-164 [2022-01-11; online 2021-10-08]

Year 2021

PubMed DOI Crossref

Challenging conventional karyotyping by next-generation karyotyping in 281 intensively treated patients with AML.

Mareschal S, Palau A, Lindberg J, ..., Grönberg H, Lehmann S

Blood Adv 5 (4) 1003-1016 [2021-02-23; online 2021-02-17]

PubMed DOI Crossref

Genomic characterization of relapsed acute myeloid leukemia reveals novel putative therapeutic targets.

Stratmann S, Yones SA, Mayrhofer M, ..., Cavelier L, Holmfeldt L

Blood Adv 5 (3) 900-912 [2021-02-09; online 2021-02-10]

Year 2020

PubMed DOI Crossref

Identification of germline variants in adults with hemophagocytic lymphohistiocytosis.

Miller PG, Niroula A, Ceremsak JJ, ..., Berliner N, Ebert BL

Blood Adv 4 (5) 925-929 [2020-03-10; online 2020-03-10]

Abhishek Niroula DDLS Fellow

PubMed DOI Crossref

Immune profiles in acute myeloid leukemia bone marrow associate with patient age, T-cell receptor clonality, and survival.

Brück O, Dufva O, Hohtari H, ..., Pellinen T, Mustjoki S

Blood Adv 4 (2) 274-286 [2020-01-28; online 2020-01-23]

Year 2019

PubMed DOI Crossref

Impact of γδ T cells on clinical outcome of hematopoietic stem cell transplantation: systematic review and meta-analysis.

Arruda LCM, Gaballa A, Uhlin M

Blood Adv 3 (21) 3436-3448 [2019-11-12; online 2019-11-13]

PubMed DOI Crossref

ClinGen Myeloid Malignancy Variant Curation Expert Panel recommendations for germline RUNX1 variants.

Luo X, Feurstein S, Mohan S, ..., Wu D, Godley LA

Blood Adv 3 (20) 2962-2979 [2019-10-22; online 2019-10-28]

Year 2018

PubMed DOI Crossref

161533 TriKE stimulates NK-cell function to overcome myeloid-derived suppressor cells in MDS.

Sarhan D, Brandt L, Felices M, ..., Önfelt B, Miller JS

Blood Adv 2 (12) 1459-1469 [2018-06-26; online 2018-06-27]

PubMed DOI Crossref

Clinical and functional impact of recurrent S1PR1 mutations in mantle cell lymphoma.

Wasik AM, Wu C, Mansouri L, ..., Pan-Hammarström Q, Sander B

Blood Adv 2 (6) 621-625 [2018-03-27; online 2018-03-20]

Year 2017

PubMed DOI Crossref

Crosstalk between ROR1 and BCR pathways defines novel treatment strategies in mantle cell lymphoma.

Karvonen H, Chiron D, Niininen W, ..., Murumägi A, Ungureanu D

Blood Adv 1 (24) 2257-2268 [2017-11-14; online 2017-11-09]

PubMed DOI Crossref

Direct evidence for a polygenic etiology in familial multiple myeloma.

Halvarsson BM, Wihlborg AK, Ali M, ..., Hansson M, Nilsson B

Blood Adv 1 (10) 619-623 [2017-04-11; online 2017-04-07]

Abhishek Niroula DDLS Fellow